Everlab has secured $10 million in seed funding led by Left Lane Capital to support its international expansion plans into Europe, the U.S., and APAC in 2026.

Jul 21, 2025•11 days ago

Amount Raised

$10 Million

Round Type

Seed

MelbourneMedicalBiotechnologyHealth Care

Investors

Left Lane Capital

Description

Everlab, a preventive healthcare startup, has closed one of Australia’s largest seed rounds for 2025. The company will use the $10 million in funding to fuel its international expansion and grow its clinic network. Led by Left Lane Capital, this round positions Everlab for growth in multiple regions. The funds aim to develop Everlab’s platform and enhance its offerings.

Company Information

Company

Everlab

Location

Melbourne, Victoria, Australia

About

Everlab is a preventive healthcare startup that specializes in conducting full-body MRI scans to identify potential health issues in asymptomatic patients. With a focus on innovation in healthcare, Everlab aims to revolutionize early detection of medical conditions. The company has recently secured substantial funding to support its international expansion and clinic network growth.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends